Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-NTX + CM for Alcohol Dependent Frequent ED Users
NCT02445339Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol dependence, alcohol use disorder (AUD), sponsored by NYU Langone Health. Started Jul 2015; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02445339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445339.